IFNA1 and systemic lupus erythematosus: As such, enhanced signaling through type I interferon (IFN) system seen in SLE might contribute to COVID-19 pathogenesis through distinct mechanisms, either by a protective, antiviral effect, or by promoting the hyperinflammatory response seen with SARS-CoV-2 infection [17].